Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) Ticker Search
Pro Search
Index Search
 QQQ: 72.76 -1.11%   SPY: 163.45 -1.38% FAQ | Sign Up Now | Login
Profile Portfolio Notes & Links Tracked By  


  Track this member and follow their portfolio moves with tickerspy™ alerts  

spysticker


Portfolio List (1):
wayne  


Close
wayne    -0.4%

  Performance       Ideas       Community  
 
Today:
Week:
1-month:
All-time: 		-0.4%
-3.2%
-0.3%
+54.4% 		vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500: 		+1.0%
-2.7%
+1.8%
+33.6%
     
Similar Portfolios also own:
OPXA, STEM, CYTX, ASTM, KOOL, ATHX, ACTC, SRPT, COOL, CCEL
 
     
Share this portfolio on Facebook
Share this portfolio on Twitter
 
                     
     
 
Chart View
1 week
  
1 month
  
3 months
  
6 months
  
All Time
  
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Portfolio HistoryNEW    
Click a column to sort | Scroll over columns for more information
What are Alerts?
  
 Ticker Last Trade Today's Change Volume  % of
Daily		 Mkt Cap  Div Yield  % off
52wk lw		 % from
52wk hg		 Gain View as: Alerts Comments
 CGR $0.26 -0.01 -2.5% 359,844 48% $46.9M - 10% -72% -81.6%
 CRIS $3.39 -0.04 -1.2% 223,221 39% $274.9M - 27% -38% -31.9%
 CUR $1.44 +0.05 +3.6% 291,289 42% $95.6M - 243% -27% +21.0%
 GERN $1.19 +0.04 +3.5% 1,611,596 221% $149.9M - 31% -60% -42.0%
 GPL $0.78 +0.01 +0.7% 292,412 64% $106.8M - 13% -69% -69.5%
 GPR $0.07 0.00 0.0% 3,500 20% $3.2M - 117% -61% -72.5%
 MCET $0.00 0.00 0.0% 9,420,508 30% $2.0M - 30% -81% -72.3%
 MEDS $1.05 0.00 0.0% 600 113% $5.1M - 48% -48% +118.8%
 NBS $0.53 -0.01 -2.2% 326,533 52% $91.7M - 29% -38% -24.1%
 OSIR $10.49 -0.16 -1.5% 24,391 31% $350.7M - 60% -27% +108.5%
 PSTI $2.68 -0.11 -3.9% 267,723 122% $163.7M - 19% -46% +1.9%
 SVM $2.63 -0.09 -3.3% 617,691 79% $464.5M 3.5% 6% -62% -65.4%
 VODG $0.05 0.00 0.0% 1,080 14% $965.4K - 186% -67% 0.0%
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss this portfolio with spysticker
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Pluristem Provides Update on Clinical Status of IC Trials
PSTI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 19, 09:13AM from (globenewswire.com)
HAIFA, Israel, June 19, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the 2013 Wells Fargo Securities Healthcare Conference
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 11, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., June 11, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem to Receive Clinical-hold Notice From the U.S. FDA
PSTI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 04, 09:13AM from (globenewswire.com)
HAIFA, Israel, June 4, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Announces CUDC-427 (GDC-0917) Phase I Clinical Data Presented at ASCO 2013 Annual Meeting
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 03, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., June 3, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Announces Appointment of Mani Mohindru, Ph.D., as Vice President of Corporate Strategy and Investor Relations
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 31, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., May 31, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the Jefferies 2013 Global Healthcare Conference
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 30, 08:43AM from (globenewswire.com)
LEXINGTON, Mass., May 30, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem to Present at FDA Symposium
PSTI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 29, 04:13AM from (globenewswire.com)
HAIFA, Israel, May 29, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Silvercorp Declares Quarterly Cash Dividend of CAD$0.025
SVM  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 22, 06:30PM from (www.marketwire.com)





VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 22, 2013) - Silvercorp Metals  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 22, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Medistem, Inc. Appoints Herm Rosenman to Board of Directors
MEDS  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 21, 09:00AM from (www2.marketwire.com)
Medistem, Inc. (PINKSHEETS: MEDS), today announced that it has appointed Herm Rosenman to its Board of Directors and Chairman  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Announces Approval of Erivedge(R) in Australia
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., May 10, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Claude Resources Inc. Announces First Quarter Results
CGR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 09, 02:22PM


Trading Symbols

TSX - CRJ  

NYSE MKT - CGR


 more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Great Panther Silver Reports First Quarter 2013 Financial Results
GPR  GPL  
Linked by marketwire ( track newsfeed | ignore newsfeed ) - May 08, 04:05PM from (www2.marketwire.com)
GREAT PANTHER SILVER LIMITED (TSX: GPR)(NYSE MKT: GPL) ("Great Panther"; the "Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Announces First Quarter 2013 Financial Results
OSIR  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 08:00AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Curis Reports First Quarter 2013 Financial Results
CRIS  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 30, 07:13AM from (globenewswire.com)
LEXINGTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem to Present at Needham Healthcare and Oppenheimer Israeli Investment Conferences in May 2013
PSTI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 30, 03:13AM from (globenewswire.com)
HAIFA, Israel, April 30, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension
PSTI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 29, 03:13AM from (globenewswire.com)
HAIFA, Israel, April 29, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Announces First Quarter 2013 Financial Results Conference Call
OSIR  
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 05:00PM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the first quarter  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 34



Home | About | Register | My tickerspy | Logout Web site design by LightMix
© 2007-2013 Indie Research, LLC. All rights reserved.  

 

---
The information herein is provided by various sources including individual contributors not associated with Indie Research and is not guaranteed by us and does not purport to be a complete or error-free statement or summary of the available data. As such, we do not warrant, endorse or guarantee the completeness, accuracy, integrity or timelines of the information. You must evaluate, and bear all risks associated with, the use of any information provided hereunder, including any reliance on the accuracy, completeness, safety or usefulness of such information. This information is not intended to be used as the primary basis of investment decisions. It should not be construed as financial or other advice or as an offer to sell or the solicitation of an offer to buy any security in any state where such an offer or solicitation would be illegal. Any information expressed herein on this date is subject to change without notice. Any opinions or assertions contained in this information do not represent the opinions or beliefs of Indie Research, LCC or one or more of its employees, may have a position in any of the securities discussed herein. Use of the tickerspy.com, signifies your agreement to the Terms of Use.

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.


Market Data Powered by Interactive Data
Terms and Conditions

Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.
Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.
Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.
Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.
Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.
Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.
Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.
Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.